01.24.25 -- A Phase-Appropriate Approach For Assay Validation In Cell & Gene Therapies

Stem cell therapy has already revolutionized the field of oncology. But where do we go from here? Dr. Robert S. Negrin addresses three key areas of CAR T-cell therapy on the brink of innovation.

By embracing decentralized models, leveraging mobile technology, and fostering strategic partnerships, sponsors and CROs can streamline ophthalmic clinical trials.

Since life science professionals hail from diverse backgrounds, educations, and work experiences, different mentorship models serve their varied development needs and learning styles.

To realize the full value of patient-centric solutions sponsors, sites and patients all need to be continually integrated from concept to trial completion.

Drug manufacturers seek packaging that maintains integrity during processing and freezing, scales up to larger volumes easily, and remains robust throughout the temperature-controlled supply chain.